JennyJingyiFengMDMSc

Neurology • New Orleans, LA

Neuroimmunology/Multiple Sclerosis

Neuroimmunologist at Ochsner Health

Join to view full profile

Dr. Feng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Feng's full profile

Already have an account?

Office
Ochsner Health
New Orleans, LA 70121

Education & Training

Cleveland Clinic FoundationFellowship, Neuroimmunology & Multiple Sclerosis, 2018 - 2020
Cleveland Clinic FoundationResidency, Neurology, 2014 - 2018
University of Louisville School of MedicineClass of 2014
Washington University in St. LouisBA, Biology - Neuroscience

Certifications & Licensure

KY State Medical License 2020 - 2025
LA State Medical License 2021 - 2025
MS State Medical License 2021 - 2025
OH State Medical License 2014 - 2025
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Best Teaching Award Ochsner Health Department of Neurology, 2023
Best Teaching Award University of Louisville Department of Neurology, 2021

Clinical Trials

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) Start of enrollment: 2021 Dec 16
Recruiting
Phase 3
Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis Start of enrollment: 2020 Nov 06
Active, not recruiting
Phase 1
Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls. Start of enrollment: 2022 Jan 25
Active, not recruiting
Phase 4

Publications & Presentations

PubMed

4 citations
Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption.
Barry A Singer, Jenny Feng, Horacio Chiong-Rivero
Journal of Neurology. 2024-06-01
Clinical observation during alemtuzumab administration.
Chris Allen, Jenny Feng, Mark Willis, Marisa P. McGinley, Daniel Ontaneda
Multiple Sclerosis and Related Disorders. 2020-01-01
8 citations
Review Of The Safety, Efficacy And Tolerability Of Fingolimod In The Treatment Of Pediatric Patients With Relapsing-Remitting Forms Of Multiple Sclerosis (RRMS).
Jenny Feng, Mary Rensel
Pediatric Health, Medicine and Therapeutics. 2019-11-12

Press Mentions

#MSVirtual2020 – Pediatric MS Patients May Do Best on Intravenous DMTs, Study FindsSeptember 16th, 2020
ACTRIMS Forum: MS Research Updates on the Microbiome, Diet, Brain Networks, and New FrontiersMarch 6th, 2020
MS News That Caught My Eye Last Week: Remyelination Research in Animal Models, Depression and Neurological Function, Ofatumumab Approval Moves CloserMarch 2nd, 2020